Author: Stefan Seyferth

Welcome XNA Pharma  at FAU to learn more about our process of formulating and analyzing oligonucleotide lipid nanoparticles! Our particles take the next step to transfer in the TEL-Drug Delivery project  We look forward to more collaborations with XNA Pharma on TEL-Drug Delivery and more future proj...

The  Frankfurt Foundation Quality of Medicines (FFQM) honored the extraordinary achievements of Professor Gordon L. Amidon (University of Michigan, Ann Arbor, USA) in the field of pharmaceutical sciences and his outstanding contributions to improving the quality and efficacy of medicines. The awa...

The FAU welcomes the partners of the SMARTIES project funded by ZIM/BMWK (16KN070964) for the status meeting at 26 and 27 May 2025 in Erlangen to exchange actual data, create new ideas and strenghthen the network.

On 23 May 2025 at 10.15 am Vincent Lau from the Helmholtz Institute for RNA-based Infection Research in Würzburg will join us for a presentation in our DFG project „Development of a Selective Antimicrobial Cystic Fibrosis Therapy Approach". DFG Fördernummer: Fi 899/11-1 (529859253).

Follow Prof. Fischer’s talk  entiteled „Sustainability and green concepts in pharmaceutical nanoformulations“  given in the Beilstein Nanotechnology series under Archive - Beilstein-Institut  

In the „Network for Therapeutic Nucleic Acids“ experts from industry and science pool their expertise to transfer solutions from the development in the laboratory to the clinic. The network is funded by ZIM/BMWK (project number 16KN130401) from 01.03.2025 to 28.02.2026. Press release Kick-off Mee...